Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Dexmedetomidine for Emergence Delirium in Elderly Hip Replacement
NCT06579001Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in emergence delirium (ED) (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Emergence Delirium. Started Nov 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
emergence delirium (ED)
Beyond the preview
Go deeper on NCT06579001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579001.